HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress.
HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent.Our objectives...
Main Authors: | Andrew Dysangco, Ziyue Liu, James H Stein, Michael P Dubé, Samir K Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5560712?pdf=render |
Similar Items
-
Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial.
by: Samir K Gupta, et al.
Published: (2013-01-01) -
Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.
by: Frederikke F Rönsholt, et al.
Published: (2013-01-01) -
Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
by: Duale Ahmed, et al.
Published: (2018-01-01) -
Dislipidemia and systemic inflammation in HIV-infected patients against combined antiretroviral therapy.
by: V. A. Vasylenko
Published: (2018-04-01) -
Relationship between microbial translocation and endothelial function in HIV infected patients.
by: Emily Blodget, et al.
Published: (2012-01-01)